The short answer
Gilda Radner, an original Saturday Night Live star, first became ill in November 1985 and was diagnosed with ovarian cancer in October 1986, when surgery found it had already spread. She had surgery, chemotherapy, and radiation therapy, wrote candidly about her illness, and died on May 20, 1989, at age 42.
Radner first became ill in November 1985 and was diagnosed in October 1986, a gap of about eleven months.
She was diagnosed with advanced ovarian cancer in October 1986; during surgery doctors found it had spread to her liver and bowels.
Her treatment included a hysterectomy in October 1986, then chemotherapy, further surgery, and radiation therapy.
She died on May 20, 1989, at age 42.
Choose how you want to understand this
The full explanation.
Who she was
Gilda Radner was one of the original cast members of Saturday Night Live. She built characters that a generation could quote back word for word. She was married to the actor Gene Wilder.
In 1986 she was diagnosed with ovarian cancer. She died of it in 1989. In between she wrote a memoir, It's Always Something, published by Simon & Schuster in 1989, and she went looking for other people who understood what she was going through.
That last part is why her name is still attached to two institutions in cancer care. This page keeps to what those institutions document, and then explains the disease behind the story.
The diagnosis, and why 1986 was typical
Ovarian cancer is usually found late. That has not changed much since Radner's diagnosis, and the national numbers show it plainly.
SEER is the federal cancer statistics program. It tracks the stage at which each cancer is caught. Only about 22 percent of ovarian cancers are found while still in the ovary. About 18 percent have reached nearby lymph nodes. And 54 percent have already spread far by the time anyone knows.
Stage drives everything that follows:
- Localized disease: 5-year relative survival 91.9 percent.
- Regional spread: 70.1 percent.
- Distant spread: 31.5 percent.
- Unstaged: 38.5 percent.
Across all stages, 5-year survival is 52.0 percent. That covers cases found from 2016 through 2022, as does the stage split above. Looking forward instead of back, the American Cancer Society projects 21,010 new ovarian cancers in the United States in 2026, and 12,450 deaths.
Those figures explain the shape of her story better than any anecdote. Most of the survival gap in ovarian cancer is a detection gap.
The symptoms nobody can use as a test
The symptoms of ovarian cancer are real. The problem is that they are also the symptoms of a dozen harmless things. The US Preventive Services Task Force lists them as abdominal pain or pressure, bloating, constipation, urinary symptoms, back pain, and fatigue.
Then it adds the sentence that matters. These symptoms are nonspecific. They show up in healthy women and in women with late-stage ovarian cancer alike. So symptoms alone cannot sort people into risk groups.
That is the hard part of every telling of her story that ends with "she should have been heard sooner." Listening better is right. It is still not the same as having a reliable test. Our page on ovarian cancer symptoms covers which patterns are worth a same-week appointment. The ones to watch are new, ongoing, and there on most days.
Why there is still no screening test
Two tests exist and are widely available. One is transvaginal ultrasound. The other is a blood test for CA-125, a protein called cancer antigen 125 that many ovarian cancers release.
Both are useful for evaluating a woman who already has symptoms. Neither works as a screen for women who do not.
In February 2018 the USPSTF issued a D recommendation: it recommends against screening for ovarian cancer in asymptomatic women. The recommendation applies to women not known to carry a high-risk hereditary cancer syndrome. A D grade means the harms outweigh the benefits.
The reasoning is specific. The task force found good evidence that these tests do not cut ovarian cancer deaths. That holds for the ultrasound, for CA-125, and for both together. It also found good evidence of real harm. The positive predictive value is low. That means most women with an odd result do not have cancer. Those false alarms lead to surgery nobody needed, and belly surgery has its own risks.
That is a genuinely uncomfortable finding. A disease found late, with two available tests, and the evidence still says do not screen.
The family history question she left behind
The one group where the picture differs is women with a strong family history.
The USPSTF says that some women should be sent for genetic counseling, and for testing if it is called for. Those are women whose family history points to a possible harmful BRCA1 or BRCA2 variant. That is a different path from screening. It can open real options for lowering risk. Our page on genetic counseling covers what that visit involves.
This is also where her name did the most concrete work. In 1981, Dr. M. Steven Piver started a registry of families affected by ovarian cancer. He was then chair of gynecologic oncology at Roswell Park Comprehensive Cancer Center. In 1990 it was renamed the Gilda Radner Registry, with Gene Wilder's agreement. The goal was to raise awareness and support national research. It was renamed the Familial Ovarian Cancer Registry in 2013.
The registry produced published research on hereditary ovarian cancer, including a review of lessons from its first twenty years in the journal Gynecologic Oncology. Families who enrolled turned private grief into data that other families now benefit from.
Gilda's Club, and what it grew into
During treatment Radner found support at The Wellness Community, a free cancer support organization opened in 1982. The experience convinced her that this kind of place should exist everywhere.
She died before that happened. Gene Wilder, Joanna Bull, and other friends and family carried it forward. They founded Gilda's Club Worldwide and opened its first Red Door in New York City in 1995, then expanded to dozens of cities.
In 2007 the Institute of Medicine published a landmark report. It was called Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Its argument was that emotional and social needs are part of cancer care, not an extra. In 2009 The Wellness Community and Gilda's Club Worldwide merged into the Cancer Support Community. Local sites still carry the Gilda's Club name.
What her story is actually good for
It is easy to turn a story like this into a warning to trust your instincts, and stop there. The more useful reading is harder and more specific.
Ongoing symptoms deserve to be taken seriously and worked up. That holds even though symptoms alone cannot diagnose this disease. Family history deserves a real conversation, and maybe a genetics referral. That is not the same thing as a screening test. And the support side of cancer care is no longer left to luck. Radner pushed it into public view, and it now has a national report and a network of centers behind it.
If you want the clinical picture rather than the biography, start with our overview of ovarian cancer.
Cancer Explained is a free, ad-free educational project. If Gilda Radner's story helped make this disease feel more understandable, you can help keep clear cancer information free for patients and families everywhere by supporting our work.
Sources
- Roswell Park: Familial Ovarian Cancer Registry
- UPI Archives, May 20, 1989: Gilda Radner dead of cancer at 42
- Cancer Support Community: our history
- SEER Cancer Stat Facts: ovarian cancer
- USPSTF: ovarian cancer screening
- PubMed record for the registry's 20 year review
This article summarizes publicly reported information; details may evolve. Spotted an error? Please email corrections@cancerexplained.org.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.
Words to know
Tap any term to see what it means.
Common questions
What kind of cancer did Gilda Radner have?
Gilda Radner had ovarian cancer. It was diagnosed in October 1986, when surgery found the cancer had already spread to her liver and bowels. She was treated with surgery, chemotherapy, and radiation therapy, and died in May 1989.
Why was her cancer found so late?
Ovarian cancer is often called a 'silent' disease because its early symptoms are vague and easily attributed to other causes. Those symptoms include bloating, abdominal or pelvic discomfort, feeling full quickly, and fatigue. Radner first became ill in November 1985, and the cancer was identified in October 1986, by which point it had spread. Her experience helped highlight the importance of taking persistent symptoms seriously.
Is there a screening test for ovarian cancer?
There is no reliable routine screening test for ovarian cancer in women at average risk, which is part of why it is often found late. Women with a strong family history or certain inherited gene changes may be at higher risk and should discuss their situation with a doctor, who may recommend closer monitoring or genetic counseling.
How old was Gilda Radner when she died, and what is her legacy?
She died on May 20, 1989, at age 42. She wrote a candid memoir about her illness, and after her death her husband Gene Wilder and others helped establish cancer support organizations and a familial ovarian cancer program, raising lasting awareness of the disease.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-17Next planned review: 2028-07-12
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share